维普中文期刊产品整合服务
4篇 您的检索式:作者名="Nicolas Isambert"
    题名 作者 年代 出处 被引量
1Degarelix as a new antiangiogenic agent for metastatic colon cancer?显示文摘Recently,follicle stimulating hormone receptor was found to be selectively expressed by endothelial cells on tumor-associated blood vessels in a wide range of human cancers.In this context,we hypothesized that degarelix,a new gonadotropin-releasing hormone receptor antagonist developed for patients with prostate cancer,may have antiangiogenic effects via its capacity to block follicle stimulating hormone(FSH)production. We report the case of a patient with metastatic colon cancer exhibiting tumor progression after failure of all conventional chemotherapeutic regimens.The addition of degarelix to the last chemotherapeutic regimen was proposed as compassionate treatment.Degarelix induced a rapid decrease in FSH level.This treatment induced radiological stabilization and carcinoembryonic antigen stabilization during 1 year.Contrast-enhanced ultrasonography demonstrated reduction of tumor vas-clature.This case represents the first report of an antitumoral effect of degarelix in metastatic colon cancer and suggests an antiangiogenic property of this drug.Francois Ghiringhelli Nicolas Isambert Sylvain Ladoire 2013World Journal of Gastroenterology2013,19,5:2
2Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas显示文摘Antoine Italiano Angela Cioffi Nicolas Penel Matteo Giaj Levra Corinne Delcambre Elsa Kalbacher Christine Chevreau Fran?ois Bertucci Nicolas Isambert Jean‐Yves Blay Binh Bui Cristina Antonescu David R. D’Adamo Robert G. Maki Mary Louise Keohan 2011Cancer2011,,13:1
3Sorafenib in patients with progressive epithelioid hemangioendothelioma显示文摘Christine Chevreau Axel Le Cesne Isabelle Ray‐Coquard Antoine Italiano Angela Cioffi Nicolas Isambert Yves Marie Robin Charles Fournier Stéphanie Clisant Loic Chaigneau Jacques‐Olivier Bay Emmanuelle Bompas Eric Gauthier Jean Y. Blay Nicolas Penel 2013Cancer2013,,14:1
4Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group 显示文摘Patricia Pautier Anne Floquet Nicolas Penel Sophie Piperno-Neumann Nicolas Isambert Annie Rey Emmanuelle Bompas Angela Cioffi Corinne Delcambre Didier Cupissol Fran?oise Collin Jean-Yves Blay Marta Jimenez Florence Duffaud 2012The Oncologist2012,,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费